At the Bob Potokar Love Your Face foundation, we have learned a lot about Multiple Myeloma cancer, understanding what it is, common symptoms, the statistics around how many people will be diagnosed with the disease and what the odds are for survival. We know that living with the disease is possible and we know that some succumb to the devastating effects it has on a body. To be clear, we are not the experts.
Although we are not medical experts, this page aims to inform you, so together, we can spread awareness and educate others.
If you want to research Multiple Myeloma further, we suggest starting with the Multiple Myeloma Research Foundation.
Multiple myeloma is a type of blood cancer that affects plasma cells. Malignant plasma cells accumulate in bone marrow (the soft and spongy tissue at the center of your bones ) and will deplete the normal plasma cells that help fight off infection. These malignant plasma cells then create an abnormal antibody called M protein, which shows no benefit to the body and may cause tumors, kidney damage, bone destruction and damaged immune function. The marker of multiple myeloma is a high level of M protein in the blood.
Multiple myeloma is a relatively uncommon cancer. In the United States, the lifetime risk of getting multiple myeloma is 1 in 132 (0.76%). The American Cancer Society's estimates for multiple myeloma in the United States for 2023 are: About 35,730 new cases will be diagnosed (19,860 in men and 15,870 in women).
Copyright © 2024 The Bob Potokar Love Your Face Foundation - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.